# EDGAR Filing Document

**Accession Number:** 0001137883
**File Stem:** 0001104659-25-069626
**Filing Date:** 2025-7
**Character Count:** 3142
**Document Hash:** 4e467058db93bec842bf7f0964d301fe
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-069626.hdr.sgml**: 20250722

**ACCESSION NUMBER**: 0001104659-25-069626

**CONFORMED SUBMISSION TYPE**: RW

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250722

**DATE AS OF CHANGE**: 20250722

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BRAINSTORM CELL THERAPEUTICS INC.
- **CENTRAL INDEX KEY:** 0001137883
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 207273918
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** RW

**SEC ACT:**
- **SEC FILE NUMBER:** 333-288322
- **FILM NUMBER:** 251140521

**BUSINESS ADDRESS:**
- **STREET 1:** 1325 AVENUE OF AMERICAS
- **STREET 2:** 28TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** 201-488-0460

**MAIL ADDRESS:**
- **STREET 1:** 1325 AVENUE OF AMERICAS
- **STREET 2:** 28TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BRAINSTORM CELL THERAPEUTICS INC
- **DATE OF NAME CHANGE:** 20041122

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GOLDEN HAND RESOURCES INC
- **DATE OF NAME CHANGE:** 20030827

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WIZBANG TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 20010409

July 22, 2025

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | **Brainstorm Cell Therapeutics Inc.** |
|  | **Registration Statement on Form S-3** |
|  | **File No. 333-288322** |

---

Ladies and Gentlemen:

On June 25, 2025, Brainstorm Cell Therapeutics Inc., a Delaware corporation (the "<u>Company</u>"), filed a Registration Statement on Form S-3 (File No. 333-288322) (the "<u>Registration Statement</u>"), with the Securities and Exchange Commission (the "<u>Commission</u>"). In accordance with Rule 477 under the Securities Act of 1933, as amended (the "<u>Securities Act</u>"), the Company hereby respectfully makes this application to withdraw the Registration Statement, together with all exhibits thereto.

No securities have been issued or sold under the Registration Statement. The Registration Statement has not been declared effective by the Commission.

The Company respectfully requests that the Commission issue an order granting withdrawal of the Registration Statement. The Company further requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use in accordance with Rule 457(p) of the Act.

Your assistance in this matter is greatly appreciated. If you have any questions regarding this application for withdrawal, please contact me at (201) 488-0460 or the Company's counsel, Faith Charles at (212) 344-5680.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| BRAINSTORM CELL THERAPEUTICS INC. | BRAINSTORM CELL THERAPEUTICS INC. |
| By: | /s/ Chaim Lebovits |
| Name: | Chaim Lebovits |
| Title: | Chief Executive Officer |

---